nodes	percent_of_prediction	percent_of_DWPC	metapath
Thalidomide—CYP2C19—urine—bipolar disorder	0.0256	0.0755	CbGeAlD
Thalidomide—CYP1A2—urine—bipolar disorder	0.0209	0.0617	CbGeAlD
Thalidomide—CYP2C9—urine—bipolar disorder	0.0198	0.0585	CbGeAlD
Thalidomide—CYP2E1—urine—bipolar disorder	0.0188	0.0555	CbGeAlD
Thalidomide—CRBN—adrenal cortex—bipolar disorder	0.0168	0.0497	CbGeAlD
Thalidomide—NFKB1—thyroid gland—bipolar disorder	0.014	0.0413	CbGeAlD
Thalidomide—CYP2C19—blood plasma—bipolar disorder	0.0133	0.0394	CbGeAlD
Thalidomide—NFKB1—nervous system—bipolar disorder	0.0118	0.0347	CbGeAlD
Thalidomide—CRBN—thyroid gland—bipolar disorder	0.0117	0.0346	CbGeAlD
Thalidomide—NFKB1—cerebellum—bipolar disorder	0.0111	0.0327	CbGeAlD
Thalidomide—Menadione—MTHFR—bipolar disorder	0.011	1	CrCbGaD
Thalidomide—CYP1A2—blood plasma—bipolar disorder	0.0109	0.0322	CbGeAlD
Thalidomide—CYP3A5—blood plasma—bipolar disorder	0.0105	0.031	CbGeAlD
Thalidomide—FGFR2—thyroid gland—bipolar disorder	0.0105	0.031	CbGeAlD
Thalidomide—CYP2C9—blood plasma—bipolar disorder	0.0103	0.0306	CbGeAlD
Thalidomide—CRBN—nervous system—bipolar disorder	0.00986	0.0291	CbGeAlD
Thalidomide—CYP2E1—blood plasma—bipolar disorder	0.00981	0.029	CbGeAlD
Thalidomide—PTGS1—blood plasma—bipolar disorder	0.00945	0.0279	CbGeAlD
Thalidomide—CRBN—cerebellum—bipolar disorder	0.00928	0.0274	CbGeAlD
Thalidomide—PTGS2—blood plasma—bipolar disorder	0.00903	0.0267	CbGeAlD
Thalidomide—NFKB1—brain—bipolar disorder	0.00899	0.0266	CbGeAlD
Thalidomide—FGFR2—nervous system—bipolar disorder	0.00884	0.0261	CbGeAlD
Thalidomide—FGFR2—cerebellum—bipolar disorder	0.00831	0.0246	CbGeAlD
Thalidomide—CRBN—brain—bipolar disorder	0.00754	0.0223	CbGeAlD
Thalidomide—FGFR2—brain—bipolar disorder	0.00675	0.0199	CbGeAlD
Thalidomide—PTGS2—adrenal cortex—bipolar disorder	0.00458	0.0135	CbGeAlD
Thalidomide—CYP1A2—thyroid gland—bipolar disorder	0.00385	0.0114	CbGeAlD
Thalidomide—CYP1A1—thyroid gland—bipolar disorder	0.0038	0.0112	CbGeAlD
Thalidomide—CYP2E1—thyroid gland—bipolar disorder	0.00347	0.0102	CbGeAlD
Thalidomide—PTGS1—thyroid gland—bipolar disorder	0.00334	0.00986	CbGeAlD
Thalidomide—CYP1A1—nervous system—bipolar disorder	0.0032	0.00944	CbGeAlD
Thalidomide—CYP2E1—nervous system—bipolar disorder	0.00292	0.00861	CbGeAlD
Thalidomide—PTGS1—nervous system—bipolar disorder	0.00281	0.00829	CbGeAlD
Thalidomide—CYP2E1—cerebellum—bipolar disorder	0.00274	0.0081	CbGeAlD
Thalidomide—PTGS2—nervous system—bipolar disorder	0.00269	0.00793	CbGeAlD
Thalidomide—PTGS2—cerebellum—bipolar disorder	0.00253	0.00746	CbGeAlD
Thalidomide—CYP1A1—brain—bipolar disorder	0.00244	0.00722	CbGeAlD
Thalidomide—CYP2E1—brain—bipolar disorder	0.00223	0.00658	CbGeAlD
Thalidomide—PTGS1—brain—bipolar disorder	0.00215	0.00634	CbGeAlD
Thalidomide—PTGS2—brain—bipolar disorder	0.00205	0.00606	CbGeAlD
Thalidomide—FGFR2—Disease—SNAP25—bipolar disorder	0.000275	0.000423	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—TRPC3—bipolar disorder	0.000273	0.00042	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—NR1D1—bipolar disorder	0.000273	0.00042	CbGpPWpGaD
Thalidomide—NFKB1—Innate Immune System—GSK3B—bipolar disorder	0.000266	0.000409	CbGpPWpGaD
Thalidomide—FGFR2—Disease—GSK3A—bipolar disorder	0.000265	0.000408	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—ADCY2—bipolar disorder	0.000264	0.000405	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—NCAN—bipolar disorder	0.000261	0.000401	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—ADM—bipolar disorder	0.00026	0.000401	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—IMPA1—bipolar disorder	0.00026	0.0004	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—TRPC3—bipolar disorder	0.000259	0.000398	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—SLC5A3—bipolar disorder	0.000256	0.000393	CbGpPWpGaD
Thalidomide—NFKB1—Adaptive Immune System—GSK3B—bipolar disorder	0.000256	0.000393	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism of lipids and lipoproteins—PIK3C2A—bipolar disorder	0.000254	0.000391	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—PDE4B—bipolar disorder	0.000254	0.00039	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—TSHB—bipolar disorder	0.000254	0.00039	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—TACR1—bipolar disorder	0.000254	0.00039	CbGpPWpGaD
Thalidomide—FGFR2—Innate Immune System—GSK3B—bipolar disorder	0.000253	0.000388	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—NDUFV2—bipolar disorder	0.000249	0.000383	CbGpPWpGaD
Thalidomide—PTGS2—Disease—NCAN—bipolar disorder	0.000247	0.00038	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—ADM—bipolar disorder	0.000247	0.00038	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—IMPA2—bipolar disorder	0.000245	0.000377	CbGpPWpGaD
Thalidomide—FGFR2—Disease—ADCY2—bipolar disorder	0.000243	0.000374	CbGpPWpGaD
Thalidomide—FGFR2—Adaptive Immune System—GSK3B—bipolar disorder	0.000242	0.000373	CbGpPWpGaD
Thalidomide—FGFR2—Disease—TCF7L2—bipolar disorder	0.000242	0.000373	CbGpPWpGaD
Thalidomide—PTGS2—Disease—SLC5A3—bipolar disorder	0.000242	0.000373	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—S100B—bipolar disorder	0.000242	0.000372	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—AKR1C4—bipolar disorder	0.000241	0.000371	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—PDE4B—bipolar disorder	0.000241	0.00037	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—TSHB—bipolar disorder	0.000241	0.00037	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—TACR1—bipolar disorder	0.000241	0.00037	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism of lipids and lipoproteins—CLOCK—bipolar disorder	0.000239	0.000368	CbGpPWpGaD
Thalidomide—CYP2C19—Biological oxidations—POMC—bipolar disorder	0.000238	0.000366	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—NDUFV2—bipolar disorder	0.000234	0.00036	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—NDUFV2—bipolar disorder	0.000234	0.00036	CbGpPWpGaD
Thalidomide—TNF—Developmental Biology—GSK3B—bipolar disorder	0.00023	0.000353	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—S100B—bipolar disorder	0.00023	0.000353	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—AKR1C4—bipolar disorder	0.000227	0.000349	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—AKR1C4—bipolar disorder	0.000227	0.000348	CbGpPWpGaD
Thalidomide—TNF—Developmental Biology—INS—bipolar disorder	0.000226	0.000348	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—NDUFV2—bipolar disorder	0.000221	0.00034	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism of lipids and lipoproteins—CLOCK—bipolar disorder	0.000218	0.000336	CbGpPWpGaD
Thalidomide—CYP2C9—Biological oxidations—POMC—bipolar disorder	0.000217	0.000334	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—NR1D1—bipolar disorder	0.000217	0.000333	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—AKR1C4—bipolar disorder	0.000214	0.000329	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—NRG1—bipolar disorder	0.000214	0.000328	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—IMPA1—bipolar disorder	0.000213	0.000327	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—HTR1A—bipolar disorder	0.00021	0.000323	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3C2A—bipolar disorder	0.000208	0.00032	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—NCAN—bipolar disorder	0.000207	0.000319	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—TAC1—bipolar disorder	0.000207	0.000318	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—NR1D1—bipolar disorder	0.000204	0.000314	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—NR1D1—bipolar disorder	0.000204	0.000313	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—SLC5A3—bipolar disorder	0.000203	0.000312	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—DRD1—bipolar disorder	0.000203	0.000312	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—HTR2C—bipolar disorder	0.000203	0.000312	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—NRG1—bipolar disorder	0.000203	0.000312	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—HTR1A—bipolar disorder	0.000199	0.000307	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—NTRK2—bipolar disorder	0.000197	0.000304	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—DRD3—bipolar disorder	0.000197	0.000302	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—TAC1—bipolar disorder	0.000196	0.000302	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—GSK3A—bipolar disorder	0.000196	0.000301	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—NCAN—bipolar disorder	0.000195	0.0003	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—NCAN—bipolar disorder	0.000195	0.000299	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—IMPA1—bipolar disorder	0.000194	0.000298	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—HTR2C—bipolar disorder	0.000193	0.000296	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—DRD1—bipolar disorder	0.000193	0.000296	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—NR1D1—bipolar disorder	0.000192	0.000296	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—SLC5A3—bipolar disorder	0.000191	0.000294	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—DRD4—bipolar disorder	0.000191	0.000293	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—SLC5A3—bipolar disorder	0.000191	0.000293	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3C2A—bipolar disorder	0.00019	0.000292	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—NTRK2—bipolar disorder	0.000187	0.000288	CbGpPWpGaD
Thalidomide—FGFR2—Disease—NRG1—bipolar disorder	0.000187	0.000288	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism of lipids and lipoproteins—CLOCK—bipolar disorder	0.000186	0.000287	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—DRD3—bipolar disorder	0.000186	0.000287	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—GSK3A—bipolar disorder	0.000186	0.000285	CbGpPWpGaD
Thalidomide—CYP1A2—Biological oxidations—POMC—bipolar disorder	0.000185	0.000285	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—CLOCK—bipolar disorder	0.000185	0.000284	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—NCAN—bipolar disorder	0.000184	0.000283	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—DRD4—bipolar disorder	0.000181	0.000278	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—NDUFV2—bipolar disorder	0.000181	0.000278	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—TPH2—bipolar disorder	0.00018	0.000277	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—TSHB—bipolar disorder	0.00018	0.000277	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—CACNB2—bipolar disorder	0.00018	0.000277	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—SLC5A3—bipolar disorder	0.00018	0.000277	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—ADCY2—bipolar disorder	0.00018	0.000276	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—TCF7L2—bipolar disorder	0.000179	0.000275	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—DRD2—bipolar disorder	0.000178	0.000273	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—DPYD—bipolar disorder	0.000177	0.000273	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—AKR1C4—bipolar disorder	0.000175	0.000269	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—ADCY2—bipolar disorder	0.00017	0.000262	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—TCF7L2—bipolar disorder	0.00017	0.000261	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—DRD2—bipolar disorder	0.000169	0.000259	CbGpPWpGaD
Thalidomide—FGFR2—Disease—MTHFR—bipolar disorder	0.000168	0.000259	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—IMPA1—bipolar disorder	0.000166	0.000255	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—NDUFV2—bipolar disorder	0.000165	0.000254	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—CACNA1C—bipolar disorder	0.000165	0.000253	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3C2A—bipolar disorder	0.000162	0.000249	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—NTRK1—bipolar disorder	0.000161	0.000247	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—PIK3C2A—bipolar disorder	0.000161	0.000247	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—AKR1C4—bipolar disorder	0.00016	0.000246	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	0.000158	0.000244	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—NR1D1—bipolar disorder	0.000157	0.000242	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—S100B—bipolar disorder	0.000156	0.000241	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—GSK3B—bipolar disorder	0.000155	0.000238	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—NTRK1—bipolar disorder	0.000153	0.000235	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—NCAN—bipolar disorder	0.00015	0.000231	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—S100B—bipolar disorder	0.000148	0.000228	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—SLC5A3—bipolar disorder	0.000147	0.000227	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—GSK3B—bipolar disorder	0.000147	0.000226	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—CLOCK—bipolar disorder	0.000147	0.000226	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—SNAP25—bipolar disorder	0.000144	0.000221	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—NR1D1—bipolar disorder	0.000143	0.000221	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—TSHB—bipolar disorder	0.000143	0.00022	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—TPH2—bipolar disorder	0.000143	0.00022	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—CACNB2—bipolar disorder	0.000143	0.00022	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—NDUFV2—bipolar disorder	0.000141	0.000217	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—DPYD—bipolar disorder	0.000141	0.000216	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—CLOCK—bipolar disorder	0.000138	0.000212	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—NRG1—bipolar disorder	0.000138	0.000212	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—CLOCK—bipolar disorder	0.000138	0.000212	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—NCAN—bipolar disorder	0.000137	0.000211	CbGpPWpGaD
Thalidomide—PTGS2—Disease—SNAP25—bipolar disorder	0.000137	0.00021	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—AKR1C4—bipolar disorder	0.000136	0.00021	CbGpPWpGaD
Thalidomide—FGFR2—Disease—GSK3B—bipolar disorder	0.000136	0.000209	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—TSHB—bipolar disorder	0.000135	0.000207	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—TPH2—bipolar disorder	0.000135	0.000207	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—CACNB2—bipolar disorder	0.000135	0.000207	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—SLC5A3—bipolar disorder	0.000134	0.000207	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—TSHB—bipolar disorder	0.000134	0.000207	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—TPH2—bipolar disorder	0.000134	0.000207	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—CACNB2—bipolar disorder	0.000134	0.000207	CbGpPWpGaD
Thalidomide—FGFR2—Disease—INS—bipolar disorder	0.000134	0.000206	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—DPYD—bipolar disorder	0.000132	0.000204	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—DPYD—bipolar disorder	0.000132	0.000203	CbGpPWpGaD
Thalidomide—PTGS2—Disease—GSK3A—bipolar disorder	0.000132	0.000202	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—NRG1—bipolar disorder	0.000131	0.000201	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—CACNA1C—bipolar disorder	0.000131	0.000201	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—CLOCK—bipolar disorder	0.00013	0.0002	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—PIK3C2A—bipolar disorder	0.000127	0.000196	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—ADCY2—bipolar disorder	0.000127	0.000196	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—TSHB—bipolar disorder	0.000127	0.000195	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—TPH2—bipolar disorder	0.000127	0.000195	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—CACNB2—bipolar disorder	0.000127	0.000195	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	0.000126	0.000193	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—DPYD—bipolar disorder	0.000125	0.000192	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—HTR2A—bipolar disorder	0.000124	0.000191	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—CACNA1C—bipolar disorder	0.000123	0.000189	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—CACNA1C—bipolar disorder	0.000123	0.000189	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—NR1D1—bipolar disorder	0.000123	0.000189	CbGpPWpGaD
Thalidomide—PTGS2—Disease—ADCY2—bipolar disorder	0.000121	0.000186	CbGpPWpGaD
Thalidomide—PTGS2—Disease—TCF7L2—bipolar disorder	0.00012	0.000185	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—PIK3C2A—bipolar disorder	0.00012	0.000185	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—PIK3C2A—bipolar disorder	0.00012	0.000184	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—HTR2A—bipolar disorder	0.000118	0.000182	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—NCAN—bipolar disorder	0.000117	0.00018	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—CACNA1C—bipolar disorder	0.000116	0.000179	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—SLC5A3—bipolar disorder	0.000115	0.000177	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—SNAP25—bipolar disorder	0.000114	0.000176	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—IL1B—bipolar disorder	0.000114	0.000175	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—PIK3C2A—bipolar disorder	0.000113	0.000174	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	0.000112	0.000172	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—COMT—bipolar disorder	0.000109	0.000168	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—MAOA—bipolar disorder	0.000108	0.000167	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—IL1B—bipolar disorder	0.000108	0.000166	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—SNAP25—bipolar disorder	0.000108	0.000166	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—SNAP25—bipolar disorder	0.000107	0.000165	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—CLOCK—bipolar disorder	0.000107	0.000164	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—TPH2—bipolar disorder	0.000104	0.00016	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—TSHB—bipolar disorder	0.000104	0.00016	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—CACNB2—bipolar disorder	0.000104	0.00016	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—DPYD—bipolar disorder	0.000102	0.000157	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—SNAP25—bipolar disorder	0.000101	0.000156	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—ADCY2—bipolar disorder	0.000101	0.000156	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—GSK3B—bipolar disorder	0.0001	0.000154	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—POMC—bipolar disorder	9.94e-05	0.000153	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—INS—bipolar disorder	9.89e-05	0.000152	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—CLOCK—bipolar disorder	9.72e-05	0.000149	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—ADCY2—bipolar disorder	9.53e-05	0.000146	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—GSK3B—bipolar disorder	9.51e-05	0.000146	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—ADCY2—bipolar disorder	9.51e-05	0.000146	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—CACNA1C—bipolar disorder	9.5e-05	0.000146	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—TSHB—bipolar disorder	9.47e-05	0.000146	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—TPH2—bipolar disorder	9.47e-05	0.000146	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—CACNB2—bipolar disorder	9.47e-05	0.000146	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—POMC—bipolar disorder	9.43e-05	0.000145	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—INS—bipolar disorder	9.38e-05	0.000144	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—DPYD—bipolar disorder	9.32e-05	0.000143	CbGpPWpGaD
Thalidomide—PTGS2—Disease—NRG1—bipolar disorder	9.29e-05	0.000143	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—PIK3C2A—bipolar disorder	9.26e-05	0.000142	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	9.14e-05	0.00014	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—ADCY2—bipolar disorder	8.98e-05	0.000138	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—MTHFR—bipolar disorder	8.82e-05	0.000136	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—COMT—bipolar disorder	8.67e-05	0.000133	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—CACNA1C—bipolar disorder	8.66e-05	0.000133	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—MAOA—bipolar disorder	8.6e-05	0.000132	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—PIK3C2A—bipolar disorder	8.44e-05	0.00013	CbGpPWpGaD
Thalidomide—PTGS2—Disease—MTHFR—bipolar disorder	8.36e-05	0.000129	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	8.33e-05	0.000128	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—CLOCK—bipolar disorder	8.31e-05	0.000128	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—SNAP25—bipolar disorder	8.3e-05	0.000128	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—COMT—bipolar disorder	8.16e-05	0.000125	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—COMT—bipolar disorder	8.14e-05	0.000125	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—MAOA—bipolar disorder	8.1e-05	0.000125	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—TPH2—bipolar disorder	8.09e-05	0.000124	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—TSHB—bipolar disorder	8.09e-05	0.000124	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—CACNB2—bipolar disorder	8.09e-05	0.000124	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—MAOA—bipolar disorder	8.08e-05	0.000124	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—DPYD—bipolar disorder	7.96e-05	0.000122	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—COMT—bipolar disorder	7.69e-05	0.000118	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—MAOA—bipolar disorder	7.64e-05	0.000117	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—SNAP25—bipolar disorder	7.57e-05	0.000116	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—CACNA1C—bipolar disorder	7.4e-05	0.000114	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—ADCY2—bipolar disorder	7.35e-05	0.000113	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—PIK3C2A—bipolar disorder	7.21e-05	0.000111	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	7.12e-05	0.000109	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—POMC—bipolar disorder	7.06e-05	0.000109	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—INS—bipolar disorder	7.02e-05	0.000108	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—MTHFR—bipolar disorder	7e-05	0.000108	CbGpPWpGaD
Thalidomide—PTGS2—Disease—GSK3B—bipolar disorder	6.74e-05	0.000104	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—ADCY2—bipolar disorder	6.7e-05	0.000103	CbGpPWpGaD
Thalidomide—PTGS2—Disease—INS—bipolar disorder	6.65e-05	0.000102	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—MTHFR—bipolar disorder	6.59e-05	0.000101	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—MTHFR—bipolar disorder	6.58e-05	0.000101	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—SNAP25—bipolar disorder	6.47e-05	9.95e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—COMT—bipolar disorder	6.29e-05	9.68e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—MAOA—bipolar disorder	6.25e-05	9.61e-05	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—MTHFR—bipolar disorder	6.22e-05	9.56e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—COMT—bipolar disorder	5.74e-05	8.82e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—ADCY2—bipolar disorder	5.73e-05	8.81e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—MAOA—bipolar disorder	5.7e-05	8.76e-05	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—POMC—bipolar disorder	5.6e-05	8.61e-05	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—INS—bipolar disorder	5.57e-05	8.57e-05	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—POMC—bipolar disorder	5.27e-05	8.11e-05	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—POMC—bipolar disorder	5.26e-05	8.09e-05	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—INS—bipolar disorder	5.24e-05	8.06e-05	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—INS—bipolar disorder	5.23e-05	8.05e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—MTHFR—bipolar disorder	5.09e-05	7.82e-05	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—POMC—bipolar disorder	4.97e-05	7.65e-05	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—INS—bipolar disorder	4.94e-05	7.6e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—COMT—bipolar disorder	4.9e-05	7.54e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—MAOA—bipolar disorder	4.87e-05	7.49e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—MTHFR—bipolar disorder	4.64e-05	7.13e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—POMC—bipolar disorder	4.07e-05	6.26e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—INS—bipolar disorder	4.05e-05	6.22e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—MTHFR—bipolar disorder	3.96e-05	6.1e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—POMC—bipolar disorder	3.71e-05	5.7e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—INS—bipolar disorder	3.69e-05	5.67e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—POMC—bipolar disorder	3.17e-05	4.87e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—INS—bipolar disorder	3.15e-05	4.85e-05	CbGpPWpGaD
